Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
34 Cards in this Set
- Front
- Back
Purpose of Bleeding Time
|
Screen for defects of PRIMARY hemostasis. Measures in vivo plt function
|
|
Normal range for BT
|
1-9 Minutes
|
|
Causes of FALSELY increased BT
|
aspirin
other drugs that inhibit plt fctn |
|
Conditions assoc with increased BT
|
Thrombocytopenia, Platelet dysfunction, vascular abnormalities, vWF disease, Bernard-Soulier,
Glanzmann's thrombasthenia, Congenital storage pool disease, Afibrinogenemia, Ehlers-Danlos syndrome, Uremia |
|
Principle of Platelet Function Analysis
|
Test cartriges w/ membranes coated w/ platelet agonists
-whole blood aspirated under controlled flow cond thru an aperture in membrane -Plts undergo AAA on membrane surrounding aperture -time req for plt plug to occulude aperture indicates plt function |
|
Purpose of Platelet Function Analysis
|
Reliable, cost-effective
-easier than plt aggregometry |
|
Principle of Platelet Aggregation
|
-PRP measured photometrically
-aggreg agent added, plts clump, % transmittance directly prop to amt clumping in plts -Aggreg. agents: ADP, collagen, ristocetin, epinep., arachidonic acid |
|
What are the primary and secondary waves in the platelet aggregation test?
|
1=direct response of plts to aggregating reagent (shape change)
2=complete aggregation (endogenous ADP release from plt dense bodies) |
|
What's special about using ristocetin in platelet aggregometry?
|
it's action is dependent on interaction of vWF & GPIb/IX. Represents plt agglutination, not aggregation
|
|
Purpose of PT Test
|
-mainly monitor oral anticoag therapy
-screen for inherited EXTRINSIC or COMMON pathway deficiencies -acquired factor deficiencies |
|
Principle of PT Test
|
-Plasma re-Ca in presence of excess tissue factor & time for clot formation is measured
-Test bypasses intrinsic factors -unaffected by plts (because FIII has phospholipids) |
|
What is the normal range for PT test? and what caveat is there?
|
~10-14 sec
varies from lab to lab because of different techs, reagents, populations, equipment... |
|
Causes for elevated PT
|
oral anticoag therapy
vitamin K deficiency Liver disease (acquired cond) specific coag factor deficiencies inhibitor |
|
Purpose of APTT
|
-screen to eval factors in INTRINSIC pathway (eval all xcpt VII,XIII,PF3)
-acquired or inherited -monitor heparin therapy -detect inhibitors in blood |
|
Principle of APTT
|
-Ca in blood bound by NaCitrate to prevent coag
-plasma after centrifg contains all intrinsic factors xcpt Ca & plts -must add: Ca source (CaCl), Phospholipid substitute (PF3), activator (ellagic acid) |
|
normal ranges for APTT
|
- 30-40 sec
-varies lab to lab |
|
APTT increased in...
|
INTRINSIC or COMMON pathway deficiencies
heparin therapy (main use) inhibitors |
|
What does elevated APTT w/ prolonged incubation mean?
|
Fletcher factor deficiency
-incubating 10 min instead of 4 |
|
Purpose & Principle of TT
|
measures conversion of fibrinogen to fibrin after adding excess thrombin to citrated plasma
-time for clot to form measured |
|
Normal range for TT
|
10-15 sec
|
|
Causes of prolonged TT
|
Hypofibrinogenemia
Dysfibrinogenemia Paraproteins (e.g., cryoglobulin) Presence of heparin Presence of FDPs Presence of plasmin |
|
Principle of Quantitative Fibrinogen
|
ability of thrombin to convert fibrinogen to fibrn
-clotting time of diluted plasma INVERSELY prop to fibrinogen conc -excess amts thrombin added to diluted plasma & clotting time noted |
|
Normal range for Quant Fibrinogen
|
200-400 mg/dL
|
|
Causes of LOW fibrinogen levels
|
<200 in children normal!
-hypofibrinogenemia, dysfibrinogenemia -liver disease -DIC -fibrinolysis |
|
Causes of HIGH fibrinogen levels
|
Remember: Fibrinogen=Acute Phase Reactant
-Pregnancy -Trauma -estrogen therapy |
|
Purpose of FXIII screening test
|
Remember: FXIII changes H-bonds to covalent in clot
-deficiency of FXIII results in unstable clots -test is time for clot to dissolve in 5M urea. Normal=~24 hrs |
|
Principle of FDP
|
-latex particles coated w/ Ab to fibrinogen fragments D & E
-positive is agglutination |
|
Purpose of soybean trypsin inhibitor in FDP
|
prevents In vitro fibrinolysis
|
|
Normal range for FDP
|
10-40 ug/dL
|
|
Purpose of D-Dimer
|
-latex agglut for specific cross-linked fibrin derivatives w/ D-Dimer domain
-eval pts w/ DVT or PE (which have elevated values) |
|
Purpose of mixing studies
|
differentiate a factor deficiency from the presence of an inhibitor.
Mix pt. plasma w/ normal plasma. If inhibitor, will also inhibit normal factors, thus no correction |
|
What are 2 specific coagulating inhibitors, and what would the results be in mixing studies?
|
Lupus-like anticoagulant,
Factor VIII inhibitor -There will be NO CORRECTION after 2 hr incubation (FVIII inhibitor corrects after immediate, but goes away) |
|
What is the dRVVT
|
Dilute Russell's Viper Venom Time
-has venom, Ca, LIMITED conc phospholipid -venom in presence of FV, phospholipid, and Ca will activate FX => prothrmbn to thrombin -dRVVT ELEVATED w/ lupus anticoagulant |
|
What patients do we see inhibitors?
|
Chronic illness
FVIII and FIX deficiencies congenital coag deficiencies postpartum women |